Filing Flows › 8-K events › ZeroStack
ZeroStack: entry into a material definitive agreement
Form 8-K filed Nov 9, 2026 · items 1.01
What the filing says
On November 3, 2026, ZeroStack Corp. (the "Company") entered into a Share Purchase and Transfer Agreement (the "Purchase Agreement") with New Horizon Pharma B.V. (the "Purchaser") and Phatebo GmbH ("Phatebo"), pursuant to which the Company agreed to sell to the Purchaser all of the issued and outstanding shares of Phat
Read the filing on SEC EDGAR →
What usually followsAcross 23,535 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
ZeroStack at a glance
ZeroStack, Q2 2026: revenue $13.7M (+41% year over year), operating margin -177.4%. The chart follows the revenue to costs, profit and cash.
ZeroStack: every quarter, Q/Q and Y/Y, holders and guidance →
ZeroStack’s other material 8-Ks
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.